Role of nitric oxide in obstetrics

Prenatal and Neonatal Medicine

Volumn 1, Issue 4, 1996, Pages 292-328

  Chwalisz, K ^a   Buhimschi, I ^b   Garfield, R E ^b  

^a BAYER PHARMA AG   (Germany)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cervix; Implantation; Nitric oxide; Ovulation; Parturition; Pre eclampsia; Preterm birth; Steroidogenesis; Uterus

Indexed keywords

EID: 0000023830     PISSN: 13598635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (227)

1. Garfield RE, Yallampalli C. Control of myometrial contractility and labor. In Chwalisz K, Garfield RE, eds. Basic Mechanisms Controlling Term and Preterm Birth. Berlin: Springer Verlag, 1993;1-29
2. Chwalisz K, Garfield RE. Antiprogestins in the induction of labor. Ann NY Acad Sci 1994;734:387-413
3. Garfield RE. Role of cell-to-cell coupling in control of myometrial contractility and labor. In Garfield RE, Tabb TN, eds. Control of Uterine Contractility. CRC Press, 1994:40-81
4. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetycholine. Nature (London) 1980; 288:373-6
5. Moncada S, Higgs EA. The L-arginine-nitric oxide pathway. New Engl J Med 1993;329:2002-12
6. Ignarro LG. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21
7. Nathan C, Qia-wen Xie. Nitric oxide synthases: roles, tolls, and controls. Cell 1994;78:915-18
8. Matthews JR, Botting CH, Panico M, Morris HR, Hay RT. Inhibition of NF-κB DNA binding by nitric oxide. Nucl Acid Res 1996;24:2236-42
9. Buhimschi I, Ali M, Jain V, Chwalisz K, Garfield RE. Differential regulation of nitric oxide in the uterus and cervix during pregnancy and labour. Hum Reprod 1996;11:101-12
10. Weiner CP, Lizasoain I, Baylis SA, Knowles RC, Charls IC, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994;91:5212-16
11. Weiner CP, Knowles RG, Moncada S. Induction of nitric oxide synthases early in pregnancy. Am J Obstet Gynecol 1994;171:838-43
12. Stamfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63
13. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. J Am Med Assoc 1991; 265:1861-7
14. Collins P. Vascular effects of oestrogen. Maturitas 1996;23:217-26
15. Krattenmacher R, Dobrindt C, Hegele-Hartung C. Effects of drospirenone on blood pressure and heart rat in rats measured by highly sensitive radiotelemetry. Gynecol Endocrinol 1996;10 (Suppl. 2):183-5
16. Magness RR, Gant NF. Control of vascular reactivity in pregnancy: the basis for therapeutic approaches to prevent pregnancy-induced hypertension. Semin Perinatol 1994;18:45-69
17. Gilligan DM, Badar DA, Guetta V, Quyyumi AA, Panza JA, Cannon RO. Estradiol potentiation of endothelium-dependent vasodilation is dependent on nitric-oxide production. J Am Coll Cardiol 1994; Spec. Issue: 378A
18. Miller VM, Vanhoutte PM. 17β-Estradiol auguments endothelium-dependent contractions to arachidonic acid in rabbit aorta. Am J Physiol 1990;258:R1502-7
19. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am Physiol Soc 991;261:R1022-7
20. Figueroa JP, Massmann GA. Estrogen increases nitric oxide synthase activity in the uterus of nonpregnant sheep. Am J Obstet Gynecol 1995;173:1539-45
21. Chaves MC, Ribeiro RA, Rao VS. Possible involvement of nitric oxide in estrogen-induced uterine edema in the immature rat. Braz J Med Biol Res 1993;26:853-7
22. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol 1991;104:1033-42
23. Arnal JF, Clamens S, Pechet C, Negre Salvayre A, Allera C, Girolami JP, Salvayre R, Bayard F. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA 1996;93:4108-13
24. Delyani JA, Murohara T, Nossuli TO, Lefer AM. Protection from myocardial reperfusion injury by acute administration of 17-beta-estradiol. J Mol Cell Cardiol 1996;28:1001-8
25. Ralevic V, Burnstock G. Mesenteric arterial function in the rat in pregnancy: role of sympathetic and sensory-motor perivascular nerves, endothelium, smooth muscle, nitric oxide and prostaglandins. Br J Pharmacol 1996;117:1463-70
26. Vedernikov YP, Liao QP, Jain V, Saade GR, Chwalisz K, Garfield RE. Regulation of vascular adaptation during pregnancy: effects of nitric oxide inhibition and steroid hormones. Am J Obstet Gynecol 1997; in press
27. Qing SS, Fähnrich M, Hasan SH, Elger W. PGFM and sex steroid concentration throughout the oestrus cycle and pregnancy in the guinea pig: effects of treatment with the progesterone antagonist ZK 98 299. In Puri CP, Van Look PFA, eds. Hormone Antagonists for Fertility Regulation. Bombay, India: Good Print, 1988: 87-99
28. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, Mosher MD. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993;7:566-71
29. Penson DF, Ng C, Cai L, Rajfer J, Gonzalez Cadavid NF. Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat. Biol Reprod 1996;55:567-74
30. Garban H, Marquez D, Cai L, Rajfer J, Gonzalez Cadavid NF. Restoration of normal adult penile erectile response in aged rats by long-term treatment with androgens. Biol Reprod 1995;53:1365-72
31. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990;87:10043-7
32. Rees DD, Cellek S, Palmer RMJ, Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide syntase and the associated effects on vascular tone. Biochem Biophys Res Commun 1990;173:541-7
33. Di Rosa M, Radomski M, Canrnuccio R, Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 1990;172:1246-52
34. Kelly RW. Pregnancy maintenance and parturition: the role of prostaglandin in manipulating the immune and inflammatory response. Endocr Rev 1994;15:684-706
35. Peplow PV. Actions of cytokines in ralation to arachidonic acid metabolism and eicosanoid production. Prostaglandins Leukotrienes Essent Fatty Acids 1996;54:303-17
36. Di Rosa M, Ialenti A, Ianaro A, Sautebin L. Interaction between nitric oxide and cyclooxygenase pathways. Prostaglandins, Leukotrienes Essent Fatty Acids 1995;54:229-38
37. Chwalisz K. Role of progesterone in the control of labor. In Chwalisz K, Garfield RE, eds. Basic Mechanisms Controlling Term and Preterm Labor. Ernst Schering Research Foundation Workshop 7. Berlin, Germany: Springer Verlag 1993:97-163
38. Snyder GD, Holmes RW, Bates JN, Van Voorhis BJ. Nitric oxide inhibits aromatase activity: mechanisms of action. J Steroids Biochem Mol Biol 1996;58:63-9
39. Kugu K, Dharmarajan AM, Preutthipan S, Wallach EE. Role of calcium/calmodulin-dependent protein kinase II in gonadotrophin-induced ovulation in in vitro perfused rabbit ovaries. J Reprod Fertil 1995; 103:273-8
40. Bonello N, McKie K, Jasper M, Andrew L, Ross N, Braybon E, Brannstrom M, Norman RJ. Inhibition of nitric oxide: effects on interleukin-1 beta-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat. Biol Reprod 1996;54:436-45
41. Van Voorhis BJ, Dunn MS, Snyder GD, Weiner CP. Nitric oxide: an autocrine regulator of human granulosa-luteal cell steroidogenesis. Endocrinology 1994;135:1799-806
42. Olson LM, Jones Burton CM, Jablonka Shariff A. Nitric oxide decreases estradiol synthesis of rat luteinized ovarian cells: possible role for nitric oxide in functional luteal regression. Endocrinology 1996; 137:3531-9
43. Adams ML, Nock B, Truong R, Cicero TJ. Nitric oxide control of steroidogenesis: endocrine effects of NG-nitro-L-arginine and comparisons to alcohol. Life Sci 1992;50:35-40
44. Adams ML, Meyer ER, Cicero TJ. Effects of nitric oxide-related agents on opioid regulation of rat testicular steroidogenesis. Biol Reprod 1996;54: 1128-34
45. Welch C, Watson ME, Poth M, Hong T, Francis GL. Evidence to suggest that nitric oxide is an interstitial regulator of Leydig cell steroidogenesis. Metabolism 1995;44:234-8
46. Adams ML, Meyer ER, Sewing BN, Cicero TJ. Effects of nitric oxide-related agents on rat testicular function. J Pharmacol Exp Ther 1994;269:230-7
47. Bonavera JJ, Sahu A, Kalra PS, Kalra SP. Evidence that nitric oxide may mediate the ovarian steroid-induced luteinizing hormone surge: involvement of excitatory amino acids. Endocrinology 1993;133:2481-7
48. Bonavera JJ, Kalra PS, Kalra SP. L-arginine/nitric oxide amplifies the magnitude and duration of the luteinizing hormone surge induced by estrogen: involvement of neuropeptide Y. Endocrinology 1996; 137:1956-62
49. Bonavera JJ, Sahu A, Kalra PS, Kalra SP. Evidence in support of nitric oxide (NO) involvement in the cyclic release of prolactin and LH surges. Brain Res 1994;660:175-9
50. Ceccatelli S, Hulting AL, Zhang X, Gustafsson L, Villar M, Hokfelt T. Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. Proc Natl Acad Sci USA 1993;90:11292-6
51. Shukovski L, Tsafriri A. The involvement of nitric oxide in the ovulation process in the rat. Endocrinology 1994;135:2287-90
52. Powers RW, Chen L, Russel PT, Laresen WJ. Gonadoptropin-stimulated regulation of blood-follicle barrier is mediated by nitric oxide. Am J Physiol 1995;269:E290-8
53. Haddad EK, Duclos AJ, Baines MG. Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells. J Exp Med 1995; 182:1143-51
54. Novaro V, Rettori V, Gonzalez ET, Jawerbaum A, Faletti A, Canteros G, De Gimeno MAF. Interaction between uterine PGE and PGF-2alpha production and the nitridergic system during embryonic implantation in the rat. Prostaglandins 1996;51:363-76
55. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993;75:1273-86
56. Wei XG , Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Moncada S, Liew FY. Altered immuno responses in mice lacking inducible nitric oxide synthesis. Nature (London) 195;375:408-11
57. Huang PL, Huang Z, Mashimo H, Blocj KD, Moskowitz MA, Bevan JA, Fishman MC Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (London) 1995;377:239-42
58. Berkovitz GS, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 1993;15:414-43
59. Creasy RK. Preterm birth prevention: where we are? Am J Obstet Gynecol 1993;168:1223-30
60. Haywood JL, Goldenberg RI, Bronstein J, Nelson KG, Waldemar AC Comparison of perceived and actual rates of survival and freedom from handicap, in premature infants. Am J Obstet Gynecol 1994;171:432-9
61. Iams JD (ed.) Preterm labor. Clin Obstet Gynecol 1995;38:673-810
62. Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD, Hobbins JC. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988;12:262-79
63. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nature Med 1995;1:460-3
64. Jain V, Yedernikov, Saade GR, Chwalisz K, Garfield RE. The relaxation responses to corticotrophin-releasing factor in rat aorta are endothelium dependent and gestationally regulated. Am J Obstet Gynecol 1997; in press
65. Higby K, Xenakis EMJ, Pauerstein CJK. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993;168:1247-59
66. Garfield RE, Yallampalli C. Structure and function of uterine muscle. In Chard T, Grudzinskas JG, eds. The Uterus. Cambridge Reviews in Human Reproduction. (Cambridge, UK: Cambridge University Press) 1994;54-93
67. Garfield RE, Ali M, Yallampalli C, Izumi H. Role of gap junctions and nitric oxide in control of myometrial contractility. Semin Perinatol 1995;19:41-51
68. Chwalisz K, Garfield RE. Role of progesterone during pregnancy: models of parturition and preeclampsia. Z Geburtsh Perinat 1994;198:170-80
69. Izumi H, Yallampalli C, Garfield RE. Gestational changes in L-arginine-induced relaxation of pregnant rat and human myometrial smooth muscle. Am J Obstet Gynecol 1993;169:1327-37
70. Chwalisz K, Ciesla I, Garfield RE. Inhibition of nitric oxide (NO) synthesis induces preterm parturition and preeclampsia-like conditions in guinea pigs. Soc Gynecol Invest 1994;36. Abstr. 104, 41st Annual Meeting
71. Sladek SM, Regenstein AC, Lykins D, Roberts JM. Nitric oxide synthase activity in pregnant rabbit uterus decrease on the last day of pregnancy. Am J Obstet Gynecol 1993;169:1285-91
72. Buhimschi I, Yallampalli C, Dong Y-L, Garfield RE. Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol 1995;172:1577-84
73. Yallampalli C, Buhimschi I, Chwalisz K, Garfield RE, Yuan-Lin Dong. Preterm birth in rats produced by synergistic action of a nitric oxide inhibitor (NG-nitro-L-arginine methyl ester) and an antiprogestin (onapristone). Am J Obstet Gynecol 1996;175:207-12
74. Buhimschi C, Buhimschi I, Chwalisz K, Garfield RE. Contrasting effects of DETA/NO, a spontaneously releasing nitric oxide donor, on pregnant rat uterine contractility in vitro versus in vivo. Am J Obstet Gynecol 1997; in press
75. Jennings RW, MacGillvray TE, Harrison MR. Nitric oxide inhibits preterm labor in the rhesus monkey. J Matern Fetal Med 1993;2:170-5
76. Peng AT, Gorman RS, Shulman SM, DeMarchis E. Intravenous nitroglycerin for uterine relaxation in the postpartum patient with retained placenta. Anesthesiology 1989;7:173
77. DeSimone CA, Norris MC, Leighton BL. Intravenous nitroglycerin aids manual extraction of a retained placenta. Anesthesiology 1990;73:787
78. Altabef KM, Spencer JT, Zinberg S Intravenous nitroglycerin for relaxation of an inverted uterus. Am J Obstet Gynecol 1992;166:1237-8
79. Rolbin SH, Hwe EM, Bernstein A Uterine relaxation can be life saving (Letter) Can J Anaesth 199;38: 939-40
80. Greensporn JS, Kovacis A A breech extraction facilitated by glycerol trinitrate spray. Lancet 1991; 338:124-5
81. Lees C, Campbell S, Jauniaux E, Brown R, Ramsay B, Gibb D, Moncada S, Martin JF. Arrest of preterm labor and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet 1994;343:1325-6
82. Black RS, Flint S, Lees C, Campbell S. Preterm labour and delivery. Eur J Pediatr 1996;155 (Suppl 2):2-7
83. Black RS. Glycerol trinitrate and preterm labour: studies in progress. Nitric Oxide in Obstetrics and Gynaecology. Recent Developments. London, June 29-30, Book of Abstracts:19
84. Chwalisz K, Hegele-Hartung CH, Schulz R, Shi Shao Qing, Louton PT, Elger W. Progesterone control of cervical ripening - experimental studies with the progesterone antagonists onapristone, lilopristone and mifepristone. In Leppert P, Woessner F, eds. The Extracellular Matrix of the Uterus, Cervix and Fetal Membranes: Synthesis, Degradation and Hormonal Regulation. Perinatology Press, 1991;119-31
85. Leppert PC. Cervical softening, effacement and dilatation: a complex biochemical cascade. J Matern Fetal Med 1992;1:213-23
86. Jungueira LCU, Zugaib M, Montes GS, Toledo OMS, Krisztan RM, Shigihara KM. Morphologic and histochemical evidence for the occurence of collagenolysis and for the role of neutrophylic polymorphnuclear leukocytes during cervical dilatation. Am J Obstet Gynecol 1980;138:273-81
87. Hegele-Hartung C, Chwalisz K, Beier HM, Elger W Ripening of the uterine cervix of the guinea pig after treatment with the progesterone antagonist onapristone (ZK 98 299): an electron microscopic study. Hum Reprod 1989;4:369-77
88. Chwalisz K. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery. Hum Reprod 1994;9 (Suppl. 1):131-61
89. Shi Shao Qing, Diel P, Fritzemeier KH, Garfield RE, Chwalisz K. The specific cyclooxygenase-2 (COX-2) inhibitor flosulide inhibits antiprogestin-induced preterm birth (Abstr.). J Soc Gynecol Invest 1996;3 (Suppl):540
90. Evans CH, Stefanovic-Racic M, Lancaster J. Nitric oxide and its role in orthopaedic disease. Clin Orthop Rel Res 1995;312:275-94
91. Shi Shao Qing, Beier HM, Garfield RE, Chwalisz K. Local application of a nitric oxide (NO) donor induces cervical ripening (Abstr.). J Soc Gynecol Invest 1996;3 (Suppl):462
92. Trachtman H, Futterweit S, Garg P, Reddy K, Singhal PC. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem Biophys Res Commun 1996;218:704-8
93. Xie W, Chipman JG, Robertson DL, Erickson RL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulating by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-6
94. Sirois J, Richards JS. Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic godadotropin in granulosa cells of rat preovulatory follicles. J Biol Chem 1992;267:6382-8
95. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needelman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993;90:7240-4
96. Salvemini D, Misko TP, Masferrer J, Seibert K, Currie MG, Needelman P. Role of nitric oxide in the regulation of cyclooxygenase. In Moncada S, Feelish M, Busse R, eds. Biology of Nitric Oxide. 4 Enzymology, Biochemistry and Immunology. London: Portland Press, 1995
97. De Swiet M The physiology of normal pregnancy. In Rubin PC, ed. Handbook of Hypertension: Hypertension in Pregnancy, vol.10. Amsterdam: Elsevier, 1988:1-8
98. Roberts JM. Pregnancy related hypertension. In Creasy RK, Resnik R, eds. Maternal Fetal Medicine: Principles and Practice. Philadelphia: WB Saunders, 1994
99. Redman CWG. The placenta, pre-eclampsia and chronic villitis. In Redman CWG, Sargent LL, Starkey M, eds. The Human Placenta. Oxford: Blackwell Scientific Publications, 1993
100. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers GM, McLaughlin K. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol 1989;161:1025-34
101. Walsh SW, Wang Y. Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol 1993;169:1456-61
102. Stark JM. Pre-eclampsia and cytokine-induced oxidative stress. Br J Obstet Gynaecol 1993;100:105-9
103. Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW. A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 1994;171:158-64
104. Sattar N, Gaw A, Packard CJ, Greer IA. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in preeclampsia. Br J Obstet Gynaecol 1996;103:614-20
105. Gant NF, Chand S, Whalley PJ et al. The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet Gynecol 1974;43:854
106. Gant NF, Daley GL, Chand S, Whaley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52:2682
107. Rubanyi GM, Polokoff ME. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:325-415
108. Friedman SA, Lubarsky SL, Ahokas RA, Nova A, Sibai BM. Preeclampsia and related disorders: clinical aspects and relevance of endothelin and nitric oxide. Clin Perinatol 1995;22:343-55
109. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161: 1200-4
110. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341: 1447-51
111. Ballegeer VC, Spitz B, De Beane LA, Van Aasche AF, Hidajat M, Criel AM. Platelet activation and vascular damage in gestational hypertension. Am J Obstet Gynecol 1992;166:629-33
112. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170:1752-9
113. Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Socol ML. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996;88:420-7
114. Walsh SC. Lipid peroxidation in pregnancy. Hypertens Pregnancy 1994;13:1-32
115. Walsh SW. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985;152:335
116. Fitzgerald DJ, Entman SS, Mulloy K et al. Decreased prostacyclin biosynthesis preceding the clinical manifestations of pregnancy-induced hypertension. Circulation 1987;75:956
117. 2 synthesis in pregnancy-induced hypertension. Lancet 1990;335:751
118. Remuzzi G, Marchesi D, Mecca G et al. Reduction of fetal vascular prostacyclin activity in pre-eclampsia. Lancet 1980;2:310
119. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol 1988;71:122-37
120. Glance DE, Elder MG, Myatt L. The actions of prostaglandins and their intaractions with angiotensin II in the isolated perfused human cotyledon. Br J Obstet Gynaecol 1986;93:488
121. Phernetton TM, Rankin JHG. Effect of prostaglandin blood flow on ovine maternal and fetal adrenal blood flows. Proc Soc Exp Biol Med 1979;162:324
122. Husslein P, Gitsch E, Pateisky N, Philipp K, Leodolter S, Sizinger H. Prostacyclin does not influence placental blood pool in vivo. Gynecol Obstet Invest 1985; 19:78
123. Fidler J, Bennett MJ, De Swiet M et al. Treatment of pregnancy hypertension with prostacyclin. Lancet 1980;2:31
124. Lewis PJ, Shepard GL, Ritter J et al. Prostacylin in preeclampsia. Lancet 1981;1:559
125. Belch JJF, Thorburn J, Greer IA et al. Intravenous prostacyclin in the management of pregnancies complicated by severe hypertension. Clin Exp Hypertens Pregnancy 1985;B4:75
126. Steel SA, Pearce JM. Specific therapy in severe growth retardation: failure of prostacyclin. J R Soc Med 1988;81:214-16
127. Massoti G, Galanti G, Pogessi L, Abbate R, Neri-Serneri GG. Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet 1979;2:1213
128. CLASP Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:619-29
129. Romero R, Lockwood C, Oyarzun E, Hobbins J. Toxemia: new concepts in an old disease. Semin Perinatol 1988;12:302-23
130. Brosens I, Robertson WB, Dixon HG The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol 1967;93:569-79
131. Brosens I The utero-placental vessels at term - the distribution and extent of physiological changes. Trophoblast Res 1988;3:61-8
132. Bernischke KI, Kaufmann P. Pathology of the Human Placenta, 3rd edn. New York: Springer Verlag, 1995
133. Pijnenborg R, Robertson WB, Brosens I, Dixon G. Trophoblast invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1981;2:71-92
134. Brosens I, Robertson WD, Dixon HG. The role of spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Ann 1972;1:177-91
135. Robertson WB, Khong TY, Brosens I, Wolf FD. The placental bed biopsy: review from three European centers. Am J Obstet Gynecol 1986;159:401
136. Sheppard R, Bonnar J. The maternal blood supply to the placenta in pregnancy complicated by intrauterine fetal growth retardation. Trophoblast Res 1988;3: 69-82
137. DeWolf F, Robertson WB, Brosens I. The ultrastructure of acute atherosis in hypertensive pragnancy. Am J Obstet Gynecol 1975;123:164
138. Campbell S, Diaz-Recasens J, Griffen DR et al. New Doppler technique for assessing uteroplacental blood flow. Lancet 1983;1:675-7
139. Bower SJ, Harrinton KF, Schuchter K, McGirr C, Campbell S. Prediction of pre-eclampsia by abnormal uterine Doppler ultrasound and modification by aspirin. Br J Obstet Gynaecol 1996;103:625-9
140. De Groot CJM, O'Brien TJ, Tylor RN. Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destinated to have preeclamspia. Am J Obstet Gynecol 1996;175:25-9
141. Giudice LC, Irwin JC, Dsupin BA, de la Fuentas L, Jin IH, Vu TH, Hoffman AR. Insulin-like growth factors (IGFs), IGF binding proteins (IGFBPs) and IGFBP protease in human uterine endometrium: their potential relevance to endometrial cyclic function and maternal-embryonic interactions. In Baxter RC, Gluckma PD, and Rosenfeld RG, eds. The Insulin-like Growth factors and their Regulatory Proteins. Amsterdam: Elsevier Science, 1994:351-61
142. Genbacev O, Joslin RJ, Damsky CH, Polliotto BM, Fisher SJ. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defect that occur in preeclampsia. J Clin Invest 1996;97:540-50
143. Thatcher CD, Keith JC. Pregnancy-induced hypertension: development of a model in the pregnant sheep. Am J Obstet Gynecol 1986;155:201
144. Wagner JE, Manning PJ. The Biology of the Guinea Pig. New York: Academic Press, 1976
145. Stout C, Lemmon WB. Glomerular capillary endothelial swelling in a pregnant chimpanzee. Am J Obstet Gynecol 1969;105:212
146. Cavanagh D, Rao PS, Knuppel RA, Desai U, Baus JU. Pregnancy-induced hypertension: development of a model in the pregnant primate (Papio anubis). Am J Obstet Gynecol 1985;151:987
147. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces symptoms identical to preeclampsia. Am J Obstet Gynecol 1993;169:1316-20
148. Molnár M, Sütö T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produced sustained hypertension, proteinuria, trombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994;170:1458-66
149. Buhimshi I, Yallampalli Y, Chwalisz K, Garfield RE. Pre-eclampsia-like conditions produced by nitric oxide inhibition: effects of L-arginine, D-arginine and steroid hormones. Hum Reprod 1995;10:2723-30
150. Helmbrecht GD, Farhat MY, Lochbaum L, Brown HE, Yadgarove KT, Eglinton GS, Ramwell PW. L-Arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am J Obstet Gynecol 1996;175:800-5
151. Molnár M, Hertelendy F. Nω-Nitro-L-arginine, an inhibitor of nitric oxide synthesis increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol 1992;166:1560-7
152. Sturgiss SN, Dunlop W, Davison JM. Renal haemodynamics and tubular function in human pregnancy. Baillière's Clin Obstet Gynecol 1994;8:209-33
153. Conrad KP. Possible mechanisms for changes in renal hemodynamics during pregnancy: studies from animal models. Am J Kidney Disease 1987;9:253-9
154. Baylis C Glomerular filtration and volume regulation in gravid models. Baillière's Clin Obstet Gynecol 1995;8:235-63
155. Baylis C. Glomerular ultrafiltration in the pseudo-pregnant rat. Am J Physiol 1982;234:F300-5
156. Lindheimer MD, Katz A. Renal physiology and disease in pregnancy. In Seldin DW, Gebisch G, eds. The Kidney: Physiology and Pathophysiology, 2nd edn. New York: Raven Press, 1992:3371-431
157. Baylis C. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992;90:278-81
158. Danielson LA, Conrad KP. Role of nitric oxide in renal hyperfiltration and vasodilation during pregnancy in chronically instrumented, conscious rats. J Clin Invest 1995;96:452-90
159. Tikkanen I, Fyhrquist F. Nitric oxide in hypertension and renal disease. Ann Med 1995;27:353-35
160. Conrad KP, Vill M, McGuire P, Dail WG, Davis AK. Expression of nitric oxide synthase by syncitiotrophoblast in human placental villi. FASEB J 1993;7:566-71
161. Maytt L, Brockman DE, Langdon J, Pollock JS. Constitutive calcium-dependent isoform of nitric oxide synthase in the human placental villous tree. Placenta 1993;14:373-83
162. Buttery LDK, McCarthy A, Springall DR, Sullivan MHF, Elder MG, Polak JM Endothelial nitric oxide synthase in the human placenta: regional distribution and proposed regulatory role at the feto-maternal interface. Placenta 1994;15:257-67
163. Buhimschi I, Yallampalli C, Chwalisz K, Garfield RE. Preeclampsia symptoms produced by nitric oxide inhibition: reversal with L-arginine and steroid hormones. Hum Reprod 1994;10:2723-30
164. Nanaev A, Chwalisz K, Frank H-G, Kohnen G, Hartung C-H, Kaufmann P. Physiological dilation of uteroplacental arteries in the guinea pig depends upon nitric oxide synthase activity of extravillous prophoblast. Cell Tissue Res 1995;282:407-21
165. Liao QP, Buhimschi I, Saade G, Chwalisz K, Garfield RE. Regulation of vascular adaptation during pregnancy: effects of nitric oxide inhibition and steroid hormones. Hum Reprod 1997; in press
166. McCarthy AL, Taylor P, Graves J, Raju SK, Poston L. Endothelium-dependent relaxation of human resistance arteries in pregnancy. Am J Obstet Gynecol 1994;171:1309-15
167. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994;171:944-8
168. Giles W, O'Callaghan S, Boura A, Walter W Reduction in human fetal umbilical-placental vascular resistance by glyceryl trinitrate. Lancet 1992;340:856
169. Ramsey B, De Belder A, Campbell S, Moncada S, Martin JF. A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia. Eur J Clin Invest 1994;24:76-8
170. Lees C, Langford E, Brown AS, de Belder A, Martin JF, Pickles A, Campbell S. The effect of S-nitrosoglutathione on platelet activation, hypertension and uterine and fetal Dopplers in severe preeclampsia. Obstet Gynecol 1996;88:14-19
171. Poston L, McCarthy AL, Ritter JM. Control of vascular resistance in the maternal and feto-placental arterial beds. Pharm Ther 1995;65:215-39
172. Baylis C, Suto T, Conrad K. Importance of nitric oxide in control of systemic and renal hemodynamics during normal pregnancy: studies in the rat and implications for preeclampsia. Hypertens Pregnancy 1996;15: 147-69
173. Morris NH, Easton BM, Dekker G. Nitric oxide, the endothelium, pregnancy and pre-eclampsia. Br J Obstet Gynaecol 1996;103:4-15
174. Neri I, Di Renzo GC, Caserta G, Gallinelli A, Facchinetti F. Impact of the L-arginine/nitric oxide system in pregnancy. Obstet Gynecol Surv 1995;50: 851-8
175. Chaudhuri G, Cuevas J, Buga GM, Ignarro LJ. NO is more important than PGI-2 in maintaining low vascular tone in feto-placental vessels. Am J Physiol 1993;265:H2036-43
176. Myatt L, Brewer A, Brockman D E. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 1991;164:687-92
177. McLaughlin MK, Conrad KP. Nitric oxide biosynthesis during pregnancy: implications for circulatory changes. Clin Exp Pharmacol Physiol 1995;22:164-71
178. Learmont JG, Poston L. Nitric oxide is involved in flow-induced dilation of isolated human small feto-placental arteries. Am J Obstet Gynecol 1996;174: 583-8
179. Chang JK, Roman C, Heymann MA. Effect of endothelium-derived relaxing factor inhibition on the umbilical-placental circulation in fetal lambs in utero. Am J Obstet Gynecol 1992;166:727-34
180. King RG, Gude NM, Di Iulio JL, Brennecke SP. Regulation of human placental fetal vessel tone: role of nitric oxide. Reprod Fertil Dev 1995;7:1407-11
181. Wieczorek KM, Brewer AS, Myatt L. Shear stress may stimulate release and action of nitric oxide in the human fetal-placental vasculature. Am J Obstet Gynecol 1995;173:708-13
182. Sooranna SR, Morris NH, Steer PJ. Placental nitric oxide metabolism. Reprod Fertil Dev 1995;7: 1525-31
183. Chaudhuri G, Furuya K. Endothelium-derived vaso-active substances in fetal placental vessels. Semin Perinatol 1991;15:63-7
184. Thaler I, Amit A, Itskovitz J. The effect of isosorbide dinitrate, a nitric oxide donor, on human uterine and placental vascular resistance in patients with preeclampsia (Abstr.). Am J Obstet Gynecol 1995;172:387
185. Bobier HS, Smith GN, Pancham SR, Brien JF. Comparative study of sodium nitroprusside induced vasodilation of human placental veins from premature and full-term normotensive and preeclamptic pregnancy. Can J Physiol Pharmacol 1995;73:1118-22
186. Nathan L, Cuevas J, Chaudhuri G. The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat. Br J Pharmacol 1995;114:955-60
187. Nobunaga T, Tokugawa Y, Hashimoto K, Kimura T, Matsuzaki N, Nitta Y, Fujita T, Kidoguchi KI, Azuma C, Saji F. Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest 1996;41:189-93
188. Davidge ST, Stranko CP, Roberts JM. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 1996;174:1008-13
189. Begum S, Yamasaki M, Mochizuki M. The role of nitric oxide metabolites during pregnancy. Kobe J Med Sci 1996;42:131-41
190. Akar F, Ark M, Uydecs BS, Soysal ME, Saracoglu F, Abacioglu N, Van de Voorde J, Kanzik I. Nitric oxide production by human umbilical vessels in severe preeclampsia. J Hypertens 1994;12:1235-41
191. Boura ALA, Walters WAW, Read MA, Leitch IM. Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol 1994;21:737-48
192. Gonzales C, Cruz MA, Gallardo V, Lagos M, Varela J, Albornoz J, Schulz C. Nitric oxide and prostaglandin systems inhibition on the isolated perfused placenta from normal and preeclamptic pregnancies. Gynecol Obstet Invest 1995;40:244-8
193. Brown MA, Tibben E, Zammitt VC, Cario GM, Carlton MA. Nitric oxide excretion in normal and hypertensive pregnancies. Hypertens Pregnancy 1995;14: 319-26
194. Orpana AK, Avela K, Ranta V, Viinikka L, Ylikorkala O. The calcium-dependent nitric oxide production of human vascular endothelial cells in preeclampsia. Am J Obstet Gynecol 1996;174:1056-60
195. Curtis NE, Gude NM, King RG, Marriott PJ, Rook TJ, Brennecke SP. Nitric oxide metabolites in normal human pregnancy and preeclampsia. Hypertens Pregnancy 1995;14:339-49
196. Boccardo P, Soregaroli M, Aiello S, Noris M, Donadelli R, Lojacono A, Benigni A. Systemic and fetal-maternal nitric oxide synthesis in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 1996;103:879-86
197. Lopez Jaramillo P, Narvaez M, Calle A, Rivera J, Jacome P, Ruano C, Nava E. Cyclic guanosine 3′,5′ monophosphate concentrations in pre-eclampsia: effects of hydralazine. Br J Obstet Gynaecol 1996;103:33-8
198. Morris NH, Sooranna SR, Learmont JG, Poston L, Ramsey B, Pearson JD, Steer PJ. Nitric oxide synthase activities in placental tissue from normotensive, preeclamptic and growth retarded pregnancies. Br J Obstet Gynaecol 1995;102:711-14
199. Wang Y, Walsh SW, Parnell R, Han J. Placental production of nitric oxide and endothelin in normal and preeclamptic pregnancies. Hypertens Pregnancy 1994; 13:171-8
200. Silver RK, Kupferminc MJ, Rissell TL, Adler L, Mullen TA, Caplan MS. Evaluation of nitric oxide as a mediator of severe preeclampsia. Am J Obstet Gynecol 1996;175:1013-17
201. Cameron IT, Van Papendorp CL, Palmer RMJ, Smith SK, Moncada S. Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertens Pregnancy 1993;12:85-92
202. Lyall F, Young A, Greer IA. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 1995;173:714-18
203. Beckman JS, Ye YZ, Anderson PG, Chen J, Accauitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 1994;375:81-8
204. Myatt L, Rosenfield RB, Eis ALW, Brockman DE, Greer I, Lyall F. Nitrotyrosine residues in placenta: evidence of peroxynitrite formation and action. Hypertension 1996;28:488-93
205. Nathan L, Cuevas J, Chaudhuri G. The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat. Br J Pharmacol 1995;114:955-60
206. Nelson SH, Steinsland OS, Johnson RL. Pregnancy-induced alterations of neurogenic constriction and dilation of human uterine artery. Am J Physiol 1995;268:H1694-701
207. Sunano S, Osugi S, Shimamura K. Blood pressure and impairment of endothelium-dependent relaxation in spontaneously hypertensive rats. Experientia 1989;45: 705-8
208. Ahokos RA, Mercer BM, Sibai BM. Enhanced endothelium-derived relaxing factor activity in pregnant spontaneously hypertensive rats. Am J Obstet Gynecol 1991;165:801-7
209. Elger W, Beier S. Überlegungen zur Bedeutung unterschiedlicher hormonaler Wirkungsspektren von Gestagenen. In Hammerstein J, ed. Aktuelle Aspekte der hormonalen Kontrazeption, Amsterdam: Excerpta Medica, 1982:9-27
210. Raynaud JP, Ojasoo T. La promégestone, un nouveau progestatif. J Gynecol Obstet Biol Reprod 1983;12: 679-710
211. Magann EF, Martin JN Jr. Complicated postpartum preeclampsia-eclampsia. Obstet Gynecol Clin North Am 1995;22:337-56
212. Kilpatrick SJ, Matthay MA. Obstetric patients requiring critical care. Chest 1992;101:1407-12
213. Usta IM, Sibai BM. Emergent management of puerperal eclampsia. Obstet Gynecol Clin North Am 1995;22:315-35
214. Fickling SA, Williams D, Vallance P, Nussey SS, Whitley G St J. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 1993;342:242-3
215. Davidge ST, Baker PN, Mcloughlin K, Roberts JM. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 1995;77:274-83
216. Edwards DL, Arora CP, Bui DT, Castro LC. Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1. Am J Obstet Gynecol 1996;175:484-8
217. De Belder AJ, MacAllister R, Radomski MW, Moncada S, Vallance PJ. Effects of S-nitrosoglutathione in human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc Res 1994;28:691-4
218. Barker DJP, Osmond C, Winter PD, Margetts B, Simmonds SJ. Weight in infancy and death from ischemic heart disease. Lancet 1989;2:577-80
219. Barker DJP. Outcome of low birthweight. Horm Res 1994;42:223-30
220. Low CM, de Swiet M, Osmond C, Fayers PM, Barker DJP, Cruddas AM, Fall CHD Initiation of hypertension in utero and its amplification throughout life. Br Med J 1993;306:204-7
221. Peters J. Molecular basis of human hypertension: the role of angiotensin. Baillière's Clin Endocrinol Metab 1995;9:657-78
222. Ward K, Hata A, Jeunemaitre X et al. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 1993;4:59-61
223. Cayatte A, Palocino JJ, Horten K et al. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arteriosclerosis Thromb 1994;14:753-9
224. Naito M, Hayashi T, Iguchi A. New approaches to prevention of atherosclerosis. Drugs 1995;50:440-53
225. Maclntyre I, Zaidi M, Alam ASMT, Datta HK, Moonga BS, Lidbury PS, Hecker M, Vane JR. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci USA 1991;88: 2936-40
226. Kasten TP, Collin-Osdoby P, Patel N, Osdoby P, Krukowski M, Misko TP, Settle SL, Currie MG, Nickols GA. Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci USA 1994;91:3569-73
227. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for adult respiratory distress syndrome. N Engl J Med 1993;328:399-405